|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 吡非尼酮治疗特发性肺纤维化患者的最新3期临床试验的结果显示文摘背景:迄今已进行了3项关于吡非尼酮治疗特发性肺纤维化(IPF)患者的有效性及安全性评价的3期临床试验,其中两项临床试验表明吡非尼酮能延缓IPF患者的疾病进展(以FVC或肺活量的变化来衡量),但另一项试验结果却并未能体现上述情况。 | King TE Bradford WZ Castro-Bernardini S 李珊 黄慧 | 2014 | 中华结核和呼吸杂志2014，37，8： | 2 |
| 2 | Prednisone,azathioprine,and N-acetylcysteine for pulmonary fibrosis显示文摘 | Raghu G Anstrom K J King TE Jr | | 0，，21： | 2 |
| 3 | Effect of interferon gam- ma-lb on survival in patients with idiopathic pulmonary fibrosis ( INSPIRE ) : a multicentre, randomized, placebo-controlled trial 显示文摘 | King TE Jr Albera C Bradford WZ | 2009 | Lancet2009，374，9685： | 1 |
| 4 | Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy显示文摘 | Selman M King TE Pardo A | 2001 | Ann Intern Med2001，134，2： | 1 |
| 5 | A clinical radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis显示文摘 | Watters LC King TE Schwarz MI | | 0，，01： | 1 |
| 6 | Hypersensitivity pneumonitis: insights in diagnosis and pathobiology显示文摘 | Selman M Prado A King TE Jr | 2012 | Am J Respir Crit Care Meal2012，186，4： | 1 |
| 7 | A phase 3 trial of pirfenidone in patients with idio- pathic pulmonary fibrosis 显示文摘 | King TE Jrl | 2014 | N Engl J Med2014，370，22： | 1 |
| 8 | Diffuse panbronchiolitis in the United States显示文摘 | King TE Lynch DA | 1996 | Am J Respir Crit Care Med1996，154，21： | 1 |
| 9 | Current perspectives on the treatment of idiopathic pulmonary fibrosis显示文摘 | WalterN Collard HR King TE Jr | 2006 | Proc Am Tho2rac Soc2006，3，： | 1 |
| 10 | Aclinical, Radio-graphic, and Physiologic scoring system for the longitudinalassessment of patients with idiopathic pulmonary fibrosis 显示文摘 | Watter LC King TE Schwarz MI | 1986 | Am Rev Respir Dis1986，133，： | 1 |
| 11 | Rapidly progressive bronchiolitis obliterans with organizing pneumonia显示文摘 | Cohen A J King TE Jr Downey GP | 1994 | Am J Respir Crit Care Med1994，149，6： | 1 |
| 12 | BUILD I : a randomized pla- ceo-controlled trim of bostentan in idiopathic pulmonary fibrosis 显示文摘 | King TE Jr Bebr J Brown KK | 2008 | Am J Respir Crit Care Med2008，177，： | 1 |
| 13 | Idiopathic pulmonary fibrosis显示文摘 | King TE Jr Pardo A Selman M | 2011 | Lancet2011，378，9807： | 1 |
| 14 | Idiopathic pulmonary fibrosis-abnormal-ities in the broncho-alverlar content of surfactant protein显示文摘 | McCormack FX King TE Voclker DR | 1991 | Respir Dis1991，144，1： | 1 |
| 15 | BU1LD-3 : a randomized, controlled trial of bosentan in idiopathi ( -pulmonary fibrosis 显示文摘 | King Jr TE Brown KK Raghu G | 2011 | Am J Respir Crit Care Med2011，184，： | 1 |
| 16 | Current perspectives on the treatment of idiopathic pulmonary fibrosis显示文摘 | Walter N Collard HR King TE Jr | 2006 | Proc Am Thorac Soc2006，3，4： | 1 |
| 17 | Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis显示文摘 | Inoue Y King TE Barker E | 2002 | Am J Respir Crit Care Med2002，166，： | 1 |
| 18 | Respiratory bronchiolitis-associated interstitial lung disease显示文摘 | King TE Jr | 1993 | Clin Chest Med1993，14，4： | 1 |
| 19 | A clinical, Radiographic, and Physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis显示文摘 | Wattcr LC King TE Sehwarz MI | 1986 | Am Rev Respir Dis1986，133，： | 1 |
| 20 | A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of pa- tients with idiopathic pulmonary fibrosis显示文摘 | Watters LC King TE Schwarz MI | 1986 | Am Rev Respir Dis1986，133，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员